{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:20:10Z","timestamp":1788600010347,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-023-01068-1","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:52:47Z","timestamp":1677016367000},"page":"592-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Surgical Management and Denosumab for Aneurysmal Bone Cysts of the Spine in an Australian Tertiary Paediatric Centre"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-6667","authenticated-orcid":false,"given":"Joel A.","family":"Vanderniet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Tsinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie-Lee","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Briody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hibbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Padhye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Biggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Dalla-Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig F.","family":"Munns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"1068_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5435\/JAAOS-20-04-233","volume":"20","author":"TB Rapp","year":"2012","unstructured":"Rapp TB, Ward JP, Alaia MJ (2012) Aneurysmal bone cyst. J Am Acad Orthop Surg 20:233\u2013241. https:\/\/doi.org\/10.5435\/JAAOS-20-04-233","journal-title":"J Am Acad Orthop Surg"},{"key":"1068_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00586-013-2715-7","volume":"22","author":"T Lange","year":"2013","unstructured":"Lange T, Stehling C, Frohlich B, Klingenhofer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jurgens H, Schulte TL (2013) Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J 22:1417\u20131422. https:\/\/doi.org\/10.1007\/s00586-013-2715-7","journal-title":"Eur Spine J"},{"key":"1068_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12891-019-2855-y","volume":"20","author":"HR Durr","year":"2019","unstructured":"Durr HR, Grahneis F, Baur-Melnyk A, Knosel T, Birkenmaier C, Jansson V, Klein A (2019) Aneurysmal bone cyst: results of an off label treatment with Denosumab. BMC Musculoskelet Disord 20:456. https:\/\/doi.org\/10.1186\/s12891-019-2855-y","journal-title":"BMC Musculoskelet Disord"},{"key":"1068_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26926","author":"N Kurucu","year":"2018","unstructured":"Kurucu N, Akyuz C, Ergen FB, Yalcin B, Kosemehmetoglu K, Ayvaz M, Varan A, Aydin B, Kutluk T (2018) Denosumab treatment in aneurysmal bone cyst: evaluation of nine cases. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26926","journal-title":"Pediatr Blood Cancer"},{"key":"1068_CR5","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/modpathol.3880224","volume":"13","author":"R Sciot","year":"2000","unstructured":"Sciot R, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Tallini G, Van den Berghe H, Vanni R, Willen H (2000) Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. a report from the CHAMP study group. Mod Pathol 13:1206\u20131210. https:\/\/doi.org\/10.1038\/modpathol.3880224","journal-title":"Mod Pathol"},{"key":"1068_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0300891618784808","volume":"104","author":"E Palmerini","year":"2018","unstructured":"Palmerini E, Ruggieri P, Angelini A, Boriani S, Campanacci D, Milano GM, Cesari M, Paioli A, Longhi A, Abate ME, Scoccianti G, Terzi S, Trovarelli G, Franchi A, Picci P, Ferrari S, Leopardi MP, Pierini M (2018) Denosumab in patients with aneurysmal bone cysts: a case series with preliminary results. Tumori 104:344\u2013351. https:\/\/doi.org\/10.1177\/0300891618784808","journal-title":"Tumori"},{"key":"1068_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2013.03.005","volume":"45","author":"AM Oliveira","year":"2014","unstructured":"Oliveira AM, Chou MM (2014) USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 45:1\u201311. https:\/\/doi.org\/10.1016\/j.humpath.2013.03.005","journal-title":"Hum Pathol"},{"key":"1068_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12178-016-9371-6","volume":"9","author":"HY Park","year":"2016","unstructured":"Park HY, Yang SK, Sheppard WL, Hegde V, Zoller SD, Nelson SD, Federman N, Bernthal NM (2016) Current management of aneurysmal bone cysts. Curr Rev Musculoskelet Med 9:435\u2013444. https:\/\/doi.org\/10.1007\/s12178-016-9371-6","journal-title":"Curr Rev Musculoskelet Med"},{"key":"1068_CR9","doi-asserted-by":"publisher","first-page":"105260","DOI":"10.1016\/j.jbspin.2021.105260","volume":"89","author":"J Maximen","year":"2022","unstructured":"Maximen J, Robin F, Tronchot A, Rossetti A, Ropars M, Guggenbuhl P (2022) Denosumab in the management of Aneurysmal bone cyst: a literature review. Joint Bone Spine 89:105260. https:\/\/doi.org\/10.1016\/j.jbspin.2021.105260","journal-title":"Joint Bone Spine"},{"key":"1068_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.trsl.2014.03.005","volume":"164","author":"DW Pelle","year":"2014","unstructured":"Pelle DW, Ringler JW, Peacock JD, Kampfschulte K, Scholten DJ 2nd, Davis MM, Mitchell DS, Steensma MR (2014) Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response. Transl Res 164:139\u2013148. https:\/\/doi.org\/10.1016\/j.trsl.2014.03.005","journal-title":"Transl Res"},{"key":"1068_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/PAT.0b013e3283463536","volume":"43","author":"KY Won","year":"2011","unstructured":"Won KY, Kalil RK, Kim YW, Park YK (2011) RANK signalling in bone lesions with osteoclast-like giant cells. Pathology 43:318\u2013321. https:\/\/doi.org\/10.1097\/PAT.0b013e3283463536","journal-title":"Pathology"},{"key":"1068_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/s1470-2045(10)70010-3","volume":"11","author":"D Thomas","year":"2010","unstructured":"Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay J-Y, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11:275\u2013280. https:\/\/doi.org\/10.1016\/s1470-2045(10)70010-3","journal-title":"Lancet Oncol"},{"key":"1068_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12957-018-1478-3","volume":"16","author":"J Engellau","year":"2018","unstructured":"Engellau J, Seeger L, Grimer R, Henshaw R, Gelderblom H, Choy E, Chawla S, Reichardt P, O\u2019Neal M, Feng A, Jacobs I, Roberts ZJ, Braun A, Bach BA (2018) Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. World J Surg Oncol 16:191. https:\/\/doi.org\/10.1186\/s12957-018-1478-3","journal-title":"World J Surg Oncol"},{"key":"1068_CR14","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S1470-2045(19)30663-1","volume":"20","author":"S Chawla","year":"2019","unstructured":"Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E (2019) Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Lancet Oncol 20:1719\u20131729. https:\/\/doi.org\/10.1016\/S1470-2045(19)30663-1","journal-title":"Lancet Oncol"},{"key":"1068_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11914-017-0380-1","volume":"15","author":"AM Boyce","year":"2017","unstructured":"Boyce AM (2017) Denosumab: an emerging therapy in pediatric bone disorders. Curr Osteoporos Rep 15:283\u2013292. https:\/\/doi.org\/10.1007\/s11914-017-0380-1","journal-title":"Curr Osteoporos Rep"},{"key":"1068_CR16","doi-asserted-by":"publisher","first-page":"e28778","DOI":"10.1002\/pbc.28778","volume":"68","author":"M Choe","year":"2021","unstructured":"Choe M, Smith V, Okcu MF, Wulff J, Gruner S, Huisman T, Venkatramani R (2021) Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer 68:e28778. https:\/\/doi.org\/10.1002\/pbc.28778","journal-title":"Pediatr Blood Cancer"},{"key":"1068_CR17","doi-asserted-by":"publisher","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","volume":"35","author":"CG Fisher","year":"2010","unstructured":"Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fourney DR (2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine oncology study group. Spine (Phila Pa 1976) 35:E1221-1229. https:\/\/doi.org\/10.1097\/BRS.0b013e3181e16ae2","journal-title":"Spine (Phila Pa 1976)"},{"key":"1068_CR18","doi-asserted-by":"publisher","first-page":"116395","DOI":"10.1016\/j.bone.2022.116395","volume":"159","author":"JA Vanderniet","year":"2022","unstructured":"Vanderniet JA, Wall CL, Mullins A, London K, Lim L, Hibbert S, Briody J, Padhye B, Poon M, Biggin A, Dalla-Pozza L, Munns CF (2022) Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre. Bone 159:116395. https:\/\/doi.org\/10.1016\/j.bone.2022.116395","journal-title":"Bone"},{"key":"1068_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000354303","volume":"80","author":"HL Ooi","year":"2013","unstructured":"Ooi HL, Briody J, Biggin A, Cowell CT, Munns CF (2013) Intravenous zoledronic acid given every 6 months in childhood osteoporosis. Horm Res Paediatr 80:179\u2013184. https:\/\/doi.org\/10.1159\/000354303","journal-title":"Horm Res Paediatr"},{"key":"1068_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.spinee.2003.07.007","volume":"4","author":"BK Kwon","year":"2004","unstructured":"Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR (2004) Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4:451\u2013464. https:\/\/doi.org\/10.1016\/j.spinee.2003.07.007","journal-title":"Spine J"},{"key":"1068_CR21","doi-asserted-by":"publisher","first-page":"e32037","DOI":"10.1371\/journal.pone.0032037","volume":"7","author":"MG Fehlings","year":"2012","unstructured":"Fehlings MG, Vaccaro A, Wilson JR, Singh A, Cadotte W, Harrop JS, Aarabi B, Shaffrey C, Dvorak M, Fisher C, Arnold P, Massicotte EM, Lewis S, Rampersaud R (2012) Early versus delayed decompression for traumatic cervical spinal cord injury: results of the surgical timing in acute spinal cord injury study (STASCIS). PLoS ONE 7:e32037. https:\/\/doi.org\/10.1371\/journal.pone.0032037","journal-title":"PLoS ONE"},{"key":"1068_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/sc.2012.59","volume":"50","author":"JR Wilson","year":"2012","unstructured":"Wilson JR, Singh A, Craven C, Verrier MC, Drew B, Ahn H, Ford M, Fehlings MG (2012) Early versus late surgery for traumatic spinal cord injury: the results of a prospective Canadian cohort study. Spinal Cord 50:840\u2013843. https:\/\/doi.org\/10.1038\/sc.2012.59","journal-title":"Spinal Cord"},{"key":"1068_CR23","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2106\/00004623-200111000-00009","volume":"83","author":"PJ Papagelopoulos","year":"2001","unstructured":"Papagelopoulos PJ, Choudhury SN, Frassica FJ, Bond JR, Unni KK, Sim FH (2001) Treatment of aneurysmal bone cysts of the pelvis and sacrum. J Bone Joint Surg Am 83:1674\u20131681. https:\/\/doi.org\/10.2106\/00004623-200111000-00009","journal-title":"J Bone Joint Surg Am"},{"key":"1068_CR24","doi-asserted-by":"publisher","first-page":"e3989","DOI":"10.7759\/cureus.3989","volume":"11","author":"I Alhumaid","year":"2019","unstructured":"Alhumaid I, Abu-Zaid A (2019) Denosumab therapy in the management of aneurysmal bone cysts: a comprehensive literature review. Cureus 11:e3989. https:\/\/doi.org\/10.7759\/cureus.3989","journal-title":"Cureus"},{"key":"1068_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/0284186X.2016.1278305","volume":"56","author":"K Boye","year":"2017","unstructured":"Boye K, Jebsen NL, Zaikova O, Knobel H, Londalen AM, Trovik CS, Monge OR, Hall KS (2017) Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort. Acta Oncol 56:479\u2013483. https:\/\/doi.org\/10.1080\/0284186X.2016.1278305","journal-title":"Acta Oncol"},{"key":"1068_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3892\/ol.2017.6379","volume":"14","author":"A Muheremu","year":"2017","unstructured":"Muheremu A, Ma Y, Huang Z, Shan H, Li Y, Niu X (2017) Diagnosing giant cell tumor of the bone using positron emission tomography\/computed tomography: a retrospective study of 20 patients from a single center. Oncol Lett 14:1985\u20131988. https:\/\/doi.org\/10.3892\/ol.2017.6379","journal-title":"Oncol Lett"},{"key":"1068_CR27","first-page":"1279","volume":"60","author":"K Hao","year":"2019","unstructured":"Hao K, Wang Q (2019) 18F-FDG PET\/CT imaging in evaluation the efficacy of denosumab for giant cell tumor of bone. J Nucl Med 60:1279\u20131279","journal-title":"J Nucl Med"},{"key":"1068_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11914-021-00657-z","volume":"19","author":"KS Pan","year":"2021","unstructured":"Pan KS, Boyce AM (2021) Denosumab treatment for giant cell tumors, aneurysmal bone cysts, and fibrous dysplasia-risks and benefits. Curr Osteoporos Rep 19:141\u2013150. https:\/\/doi.org\/10.1007\/s11914-021-00657-z","journal-title":"Curr Osteoporos Rep"},{"key":"1068_CR29","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"AM Boyce","year":"2012","unstructured":"Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, Farley FA, Molinolo AA, Bhattacharyya N, Collins MT (2012) Denosumab treatment for fibrous dysplasia. J Bone Miner Res 27:1462\u20131470. https:\/\/doi.org\/10.1002\/jbmr.1603","journal-title":"J Bone Miner Res"},{"key":"1068_CR30","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1210\/jc.2013-1143","volume":"98","author":"C Grasemann","year":"2013","unstructured":"Grasemann C, Schundeln MM, Hovel M, Schweiger B, Bergmann C, Herrmann R, Wieczorek D, Zabel B, Wieland R, Hauffa BP (2013) Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget\u2019s disease. J Clin Endocrinol Metab 98:3121\u20133126. https:\/\/doi.org\/10.1210\/jc.2013-1143","journal-title":"J Clin Endocrinol Metab"},{"key":"1068_CR31","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/pbc.25393","volume":"62","author":"N Gossai","year":"2015","unstructured":"Gossai N, Hilgers MV, Polgreen LE, Greengard EG (2015) Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone. Pediatr Blood Cancer 62:1078\u20131080. https:\/\/doi.org\/10.1002\/pbc.25393","journal-title":"Pediatr Blood Cancer"},{"key":"1068_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00774-015-0677-z","volume":"34","author":"N Setsu","year":"2016","unstructured":"Setsu N, Kobayashi E, Asano N, Yasui N, Kawamoto H, Kawai A, Horiuchi K (2016) Severe hypercalcemia following denosumab treatment in a juvenile patient. J Bone Miner Metab 34:118\u2013122. https:\/\/doi.org\/10.1007\/s00774-015-0677-z","journal-title":"J Bone Miner Metab"},{"key":"1068_CR33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1210\/jc.2017-02025","volume":"103","author":"S Uday","year":"2018","unstructured":"Uday S, Gaston CL, Rogers L, Parry M, Joffe J, Pearson J, Sutton D, Grimer R, Hogler W (2018) Osteonecrosis of the jaw and rebound hypercalcemia in young people treated with denosumab for giant cell tumor of bone. J Clin Endocrinol Metab 103:596\u2013603. https:\/\/doi.org\/10.1210\/jc.2017-02025","journal-title":"J Clin Endocrinol Metab"},{"key":"1068_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s12519-020-00378-w","volume":"16","author":"C Sydlik","year":"2020","unstructured":"Sydlik C, Durr HR, Pozza SB, Weissenbacher C, Roeb J, Schmidt H (2020) Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention? World J Pediatr 16:520\u2013527. https:\/\/doi.org\/10.1007\/s12519-020-00378-w","journal-title":"World J Pediatr"},{"key":"1068_CR35","doi-asserted-by":"publisher","first-page":"698963","DOI":"10.3389\/fendo.2021.698963","volume":"12","author":"G Del Sindaco","year":"2021","unstructured":"Del Sindaco G, Berlanga P, Brugieres L, Thebault E, Mantovani G, Wicart P, Linglart A (2021) Mineral and bone consequences of high dose denosumab therapy to treat an aneurysmal bone cyst, a child case report. Front Endocrinol (Lausanne) 12:698963. https:\/\/doi.org\/10.3389\/fendo.2021.698963","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1068_CR36","doi-asserted-by":"publisher","first-page":"101148","DOI":"10.1016\/j.bonr.2021.101148","volume":"15","author":"K Horiuchi","year":"2021","unstructured":"Horiuchi K, Kobayashi E, Mizuno T, Susa M, Chiba K (2021) Hypercalcemia following discontinuation of denosumab therapy: a systematic review. Bone Rep 15:101148. https:\/\/doi.org\/10.1016\/j.bonr.2021.101148","journal-title":"Bone Rep"},{"key":"1068_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1210\/jc.2013-3081","volume":"99","author":"HD Wang","year":"2014","unstructured":"Wang HD, Boyce AM, Tsai JY, Gafni RI, Farley FA, Kasa-Vubu JZ, Molinolo AA, Collins MT (2014) Effects of denosumab treatment and discontinuation on human growth plates. J Clin Endocrinol Metab 99:891\u2013897. https:\/\/doi.org\/10.1210\/jc.2013-3081","journal-title":"J Clin Endocrinol Metab"},{"key":"1068_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00586-018-5470-y","volume":"27","author":"DC Kieser","year":"2018","unstructured":"Kieser DC, Mazas S, Cawley DT, Fujishiro T, Tavolaro C, Boissiere L, Obeid I, Pointillart V, Vital JM, Gille O (2018) Bisphosphonate therapy for spinal aneurysmal bone cysts. Eur Spine J 27:851\u2013858. https:\/\/doi.org\/10.1007\/s00586-018-5470-y","journal-title":"Eur Spine J"},{"key":"1068_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2013.10.004","volume":"58","author":"F Cornelis","year":"2014","unstructured":"Cornelis F, Truchetet ME, Amoretti N, Verdier D, Fournier C, Pillet O, Gille O, Hauger O (2014) Bisphosphonate therapy for unresectable symptomatic benign bone tumors: a long-term prospective study of tolerance and efficacy. Bone 58:11\u201316. https:\/\/doi.org\/10.1016\/j.bone.2013.10.004","journal-title":"Bone"},{"key":"1068_CR40","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/BPO.0b013e318285c3a7","volume":"33","author":"PJ Simm","year":"2013","unstructured":"Simm PJ, O\u2019Sullivan M, Zacharin MR (2013) Successful treatment of a sacral aneurysmal bone cyst with zoledronic acid. J Pediatr Orthop 33:e61-64. https:\/\/doi.org\/10.1097\/BPO.0b013e318285c3a7","journal-title":"J Pediatr Orthop"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-023-01068-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T12:03:14Z","timestamp":1681646594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-023-01068-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["1068"],"URL":"https:\/\/doi.org\/10.1007\/s00223-023-01068-1","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"10 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Denosumab was administered following approval from the Sydney Children's Hospitals Network Drug Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Joel A. Vanderniet, Dionysios Tsinas, Christie-Lee Wall, Christian M. Girgis, Kevin London, Corinne Keane, Julie Briody, Sally Hibbert, Myra Poon, Bhavna Padhye, Andrew Biggin, Luciano Dalla-Pozza, Randolph J. Gray and Craig F. Munns have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Human Research Ethics Committee at our institution (2019\/ETH13024) and conducted in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was not required for this retrospective review of clinical data, in which no identifying details were published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}